Correlation Between Aptose Biosciences and Akebia Ther
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and Akebia Ther, you can compare the effects of market volatilities on Aptose Biosciences and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and Akebia Ther.
Diversification Opportunities for Aptose Biosciences and Akebia Ther
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aptose and Akebia is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and Akebia Ther go up and down completely randomly.
Pair Corralation between Aptose Biosciences and Akebia Ther
Given the investment horizon of 90 days Aptose Biosciences is expected to under-perform the Akebia Ther. In addition to that, Aptose Biosciences is 1.0 times more volatile than Akebia Ther. It trades about -0.09 of its total potential returns per unit of risk. Akebia Ther is currently generating about 0.24 per unit of volatility. If you would invest 179.00 in Akebia Ther on November 9, 2024 and sell it today you would earn a total of 37.00 from holding Akebia Ther or generate 20.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aptose Biosciences vs. Akebia Ther
Performance |
| Timeline |
| Aptose Biosciences |
| Akebia Ther |
Aptose Biosciences and Akebia Ther Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aptose Biosciences and Akebia Ther
The main advantage of trading using opposite Aptose Biosciences and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.| Aptose Biosciences vs. CytomX Therapeutics | Aptose Biosciences vs. Instil Bio | Aptose Biosciences vs. Spero Therapeutics | Aptose Biosciences vs. Assembly Biosciences |
| Akebia Ther vs. Protalix Biotherapeutics | Akebia Ther vs. Cidara Therapeutics | Akebia Ther vs. X4 Pharmaceuticals | Akebia Ther vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |